Advertisement

Herz

, Volume 44, Issue 2, pp 147–154 | Cite as

Vitamin D deficiency and functional response to CRT in heart failure patients

  • A. Separham
  • L. Pourafkari
  • B. Kazemi
  • Y. Haghizadeh
  • F. Akbarzadeh
  • M. Toufan
  • H. Sate
  • N. D. NaderEmail author
Original articles

Abstract

Background

Vitamin D deficiency has been associated with a poor outcome in patients with heart failure (HF). We examined the role of vitamin D in the response of HF patients to cardiac resynchronization therapy (CRT).

Methods

The study comprised 50 patients (30 men and 20 women) with HF undergoing CRT implantation who were prospectively enrolled. Response to CRT was defined as a combination of ≥15% reduction in left ventricular end-systolic volume (LVESV) and ≥10% improvement in the 6‑Minute Walk Test within 6 months. Patients were grouped based on their levels of vitamin D prior to CRT implantation. Clinical and echocardiographic examinations were performed prior to and 6 months after the procedure.

Results

Of the patients, 11 (22%) failed to respond to CRT; two patients died within 6 months and an additional nine patients showed no improvement in the 6‑Minute Walk Test and no reduction in their baseline LVESV. A comparison was made between 25 patients with sufficient levels of vitamin D and 25 patients with insufficient levels. Nine patients (36%) in the “insufficient” group and two patients (8%) in the “sufficient” group failed to respond to CRT implantation (p = 0.037).

Conclusion

Adequate serum concentrations of vitamin D play a significant role in improving the functional status of patients with systolic HF following CRT implantation.

Keywords

Systolic heart failure Cardiac resynchronization therapy Myocardial remodeling Ventricular end-systolic volume 6-Minute Walk Test 

Vitamin-D-Mangel und funktionelle Antwort auf CRT bei Herzinsuffizienzpatienten

Zusammenfassung

Hintergrund

Vitamin-D-Mangel wird mit einem ungünstigen Verlauf bei Patienten mit Herzinsuffizienz in Zusammenhang gebracht. In der vorliegenden Arbeit wurde die Bedeutung von Vitamin D für die Antwort von Herzinsuffizienzpatienten auf eine kardiale Resynchronisationstherapie (CRT) untersucht.

Methoden

Die vorliegende Studie umfasste 50 Patienten (30 m., 20 w.) mit Herzinsuffizienz und CRT-Implantation, die prospektiv in die Studie aufgenommen wurden. Als Therapieansprechen auf die CRT wurde die Kombination einer Verminderung des linksventrikulären endsystolischen Volumens (LVESV) von ≥15 % und einer Verbesserung im 6‑min-Gehtest von ≥10 % innerhalb von 6 Monaten definiert. Die Patienten wurden anhand ihrer Vitamin-D-Werte vor CRT in Gruppen eingeteilt. Eine klinische Untersuchung und eine Echokardiographie wurden vor und 6 Monate nach dem Eingriff durchgeführt.

Ergebnisse

Kein Therapieansprechen auf die CRT bestand bei 11 Patienten (22 %); 2 Patienten starben innerhalb von 6 Monaten und weitere 9 zeigten weder eine Verbesserung im 6‑min-Gehtest noch eine Verminderung ihres Ausgangs-LVESV. Es wurden 25 Patienten mit ausreichenden Vitamin-D-Werten und 25 Patienten mit nicht ausreichenden Werten verglichen. Kein Therapieansprechen auf die CRT gab es bei 9 Patienten (36 %) in der „nicht ausreichenden“ Gruppe und bei 2 Patienten (8 %) in der „ausreichenden“ Gruppe (p = 0,037).

Schlussfolgerung

Ausreichende Serumkonzentrationen von Vitamin D spielen eine bedeutende Rolle bei der Verbesserung der Leistungsfähigkeit von Patienten mit systolischer Herzinsuffizienz nach CRT-Implantation.

Schlüsselwörter

Systolische Herzinsuffizienz Kardiale Resynchronizationstherapie Myokardiales Remodeling Ventrikuläres endsystolisches Volumen 6-min-Gehtest 

Notes

Compliance with ethical guidelines

Conflict of interest

A. Separham , L. Pourafkari, B. Kazemi, Y. Haghizadeh, F. Akbarzadeh, M. Toufan, H. Sate, and N.D. Nader declare that they have no competing interests.

The study was approved by the local ethics committees of the university and all patients provided written informed consent according to the Declaration of Helsinki to participate in this study.

References

  1. 1.
    Roger VL (2013) Epidemiology of heart failure. Circ Res 113:646–659.  https://doi.org/10.1161/CIRCRESAHA.113.300268 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Costanzo MR (2017) Cardiac resynchronization therapy in women. Heart Fail Clin 13:165–178.  https://doi.org/10.1016/j.hfc.2016.07.013 CrossRefPubMedGoogle Scholar
  3. 3.
    Daubert C, Behar N, Martins RP, Mabo P, Leclercq C (2017) Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J 38:1463–1472.  https://doi.org/10.1093/eurheartj/ehw270 CrossRefPubMedGoogle Scholar
  4. 4.
    Auricchio A, Prinzen FW (2011) Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues. Circ J 75:521–527CrossRefGoogle Scholar
  5. 5.
    Carita P, Corrado E, Pontone G, Curnis A, Bontempi L, Novo G, Guglielmo M, Ciaramitaro G, Assennato P, Novo S, Coppola G (2016) Non-responders to cardiac resynchronization therapy: insights from multimodality imaging and electrocardiography. A brief review. Int J Cardiol 225:402–407.  https://doi.org/10.1016/j.ijcard.2016.09.037 CrossRefPubMedGoogle Scholar
  6. 6.
    Yu Z, Chen X, Han F, Qin S, Li M, Wu Y, Su Y, Ge J (2017) Electro-echocardiographic indices to predict cardiac resynchronization therapy non-response on non-ischemic cardiomyopathy. Sci Rep 7:44009.  https://doi.org/10.1038/srep44009 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Rinkuniene D, Bucyte S, Ceseviciute K, Abramavicius S, Baronaite-Dudoniene K, Laukaitiene J, Kazakevicius T, Zabiela V, Sileikis V, Puodziukynas A, Jurkevicius R (2014) Predictors of positive response to cardiac resynchronization therapy. BMC Cardiovasc Disord 14:55.  https://doi.org/10.1186/1471-2261-14-55 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Qiao Q, Ding LG, Hua W, Chen KP, Wang FZ, Zhang S (2011) Potential predictors of non-response and super-response to cardiac resynchronization therapy. Chin Med J (Engl) 124:1338–1441Google Scholar
  9. 9.
    Shanks M, Delgado V, Ng AC, Auger D, Mooyaart EA, Bertini M, Marsan NA, van Bommel RJ, Holman ER, Poldermans D, Schalij MJ, Bax JJ (2011) Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy. Am Heart J 161:552–557.  https://doi.org/10.1016/j.ahj.2010.11.011 CrossRefPubMedGoogle Scholar
  10. 10.
    Kamiyama Y, Suzuki H, Yamada S, Kaneshiro T, Takeishi Y (2015) Serum phosphate levels reflect responses to cardiac resynchronization therapy in chronic heart failure patients. J Arrhythm 31(1):38–42.  https://doi.org/10.1016/j.joa.2014.06.006 CrossRefPubMedGoogle Scholar
  11. 11.
    Cai C, Hua W, Ding LG, Wang J, Chen KP, Yang XW, Liu ZM, Zhang S (2014) High sensitivity C‑reactive protein and cardfiac resynchronization therapy in patients with advanced heart failure. J Geriatr Cardiol 11(4):296–302.  https://doi.org/10.11909/j.issn.1671-5411.2014.04.004 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87(4):1080S–1086SCrossRefGoogle Scholar
  13. 13.
    Wimalawansa SJ (2016) Non-musculoskeletal benefits of vitamin D. J Steroid Biochem Mol Biol.  https://doi.org/10.1016/j.jsbmb.2016.09.016 CrossRefPubMedGoogle Scholar
  14. 14.
    Separham A, Sohrabi B, Pourafkari L, Sepasi N, Ghaffari S, Aslanabadi N, Nader ND (2017) Vitamin D is a predictor of ST segment resolution and infarct size following thrombolysis in patients with acute ST elevation myocardial infarction. Turk Kardiyol Dern Ars 45(4):324–332.  https://doi.org/10.5543/tkda.2017.17737 CrossRefPubMedGoogle Scholar
  15. 15.
    Judd SE, Tangpricha V (2009) Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 338(1):40–44.  https://doi.org/10.1097/MAJ.0b013e3181aaee91 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Beveridge LA, Witham MD (2013) Vitamin D and the cardiovascular system. Osteoporos Int 24(8):2167–2180.  https://doi.org/10.1007/s00198-013-2281-1 CrossRefPubMedGoogle Scholar
  17. 17.
    Saponaro F, Marcocci C, Zucchi R, Prontera C, Clerico A, Scalese M, Frascarelli S, Saba A, Passino C (2017) Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients’ survival. Endocrine.  https://doi.org/10.1007/s12020-017-1282-9 CrossRefPubMedGoogle Scholar
  18. 18.
    Belen E, Sungur A, Sungur MA (2016) Vitamin D levels predict hospitalization and mortality in patients with heart failure. Scand Cardiovasc J 50(1):17–22.  https://doi.org/10.3109/14017431.2015.1098725 CrossRefPubMedGoogle Scholar
  19. 19.
    Witte KK, Byrom R, Gierula J, Paton MF, Jamil HA, Lowry JE, Gillott RG, Barnes SA, Chumun H, Kearney LC, Greenwood JP, Plein S, Law GR, Pavitt S, Barth JH, Cubbon RM, Kearney MT (2016) Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol 67(22):2593–2603.  https://doi.org/10.1016/j.jacc.2016.03.508 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Sunman H, Ozkan A, Yorgun H, Canpolat U, Maharjan N, Asil S, Kaya EB, Bayrak T, Tokgozoglu L, Ozkara A, Aytemir K, Oto A (2016) Vitamin D levels predict the response to cardiac resynchronization therapy in patients with systolic heart failure. Turk Kardiyol Dern Ars 44(8):670–676.  https://doi.org/10.5543/tkda.2016.28848 CrossRefPubMedGoogle Scholar
  21. 21.
    Epstein AE, DiMarco JP, Ellenbogen KA et al (2013) 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61(3):e6–75.  https://doi.org/10.1016/j.jacc.2012.11.007 CrossRefPubMedGoogle Scholar
  22. 22.
    Niafar M, Pourafkari L, Aminmozaffari S, Nader ND (2016) Association of vitamin D deficiency and thyroid function in postmenopausal women. Adv Pharm Bull 6(4):639–644.  https://doi.org/10.15171/apb.2016.078 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281.  https://doi.org/10.1056/NEJMra070553 CrossRefPubMedGoogle Scholar
  24. 24.
    Simpson RU (2011) Selective knockout of the vitamin d receptor in the heart results in cardiac hypertrophy: is the heart a drugable target for vitamin D receptor agonists? Circulation 124(17):1808–1810.  https://doi.org/10.1161/CIRCULATIONAHA.111.061234 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Meredith AJ, McManus BM (2013) Vitamin D in heart failure. J Card Fail 19(10):692–711.  https://doi.org/10.1016/j.cardfail.2013.09.002 CrossRefPubMedGoogle Scholar
  26. 26.
    Boxer RS, Kenny AM, Cheruvu VK, Vest M, Fiutem JJP II (2010) Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. Am Heart J 160(5):893–899.  https://doi.org/10.1016/j.ahj.2010.08.004 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Zittermann A, Schleithoff SS, Koerfer R (2006) Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 11(1):25–33.  https://doi.org/10.1007/s10741-006-9190-8 CrossRefPubMedGoogle Scholar
  28. 28.
    Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, Sillje HH, van Gilst WH, Jaarsma T, de Boer RA (2011) Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail 13(6):619–625.  https://doi.org/10.1093/eurjhf/hfr032 CrossRefPubMedGoogle Scholar
  29. 29.
    de Borst MH, Vervloet MG, ter Wee PM, Navis G (2011) Cross talk between the renin-angiotensin-aldosterone system and vitamin D‑FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol 22(9):1603–1609.  https://doi.org/10.1681/ASN.2010121251 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Zhang J, Ye J, Guo G, Lan Z, Li X, Pan Z, Rao X, Zheng Z, Luo F, Lin L, Lin Z, Xue Y (2016) Vitamin D status is negatively correlated with insulin resistance in Chinese type 2 diabetes. Int J Endocrinol 2016:1794894.  https://doi.org/10.1155/2016/1794894 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Amer M, Qayyum R (2012) Relation between serum 25-hydroxyvitamin D and C‑reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 109(2):226–230.  https://doi.org/10.1016/j.amjcard.2011.08.032 CrossRefPubMedGoogle Scholar
  32. 32.
    Kim SH, Baek MS, Yoon DS, Park JS, Yoon BW, Oh BS, Park J, Kim HJ (2014) Vitamin D inhibits expression and activity of matrix metalloproteinase in human lung fibroblasts (HFL-1) cells. Tuberc Respir Dis (Seoul) 77(2):73–80.  https://doi.org/10.4046/trd.2014.77.2.73 CrossRefGoogle Scholar
  33. 33.
    Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Givtaj N, Sameie N, Sadeghpour A, Haghjoo M (2009) Prediction of response to cardiac resynchronization therapy using simple electrocardiographic and echocardiographic tools. Europace 11(10):1330–1337.  https://doi.org/10.1093/europace/eup258 CrossRefPubMedGoogle Scholar
  34. 34.
    Chatterjee NA, Singh JP, Szymonifka J, Deano RC, Thai WE, Wai B, Min JK, Januzzi JL, Truong QA (2016) Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study. Int J Cardiol 205:43–49.  https://doi.org/10.1016/j.ijcard.2015.12.002 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH 2017

Authors and Affiliations

  1. 1.Cardiovascular Research CenterTabriz University of Medical SciencesTabrizIran
  2. 2.Dept. of AnesthesiologyUniversity at BuffaloBuffaloUSA

Personalised recommendations